AFT Pharmaceuticals Limited (NZE:AFT)

AFT Pharmaceuticals Ratios and Metrics

Market cap in millions NZD. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	464	352	282	328	363	378
Market Cap Growth	70.01%	24.91%	-14.06%	-9.54%	-4.00%	-26.99%
Enterprise Value	506	377	305	363	395	414
Last Close Price	4.42	3.33	2.65	3.07	3.38	3.53

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	31.57	23.92	23.58	21.03	34.06	19.04
Forward PE	23.53	18.37	16.79	19.41	19.12	18.43
PS Ratio	1.82	1.38	1.36	1.68	2.32	2.90
PB Ratio	4.25	3.23	2.91	3.74	4.95	6.07
P/TBV Ratio	5.00	3.80	3.51	4.47	6.35	8.16
P/FCF Ratio	-	-	21.88	11.42	31.74	27.34
P/OCF Ratio	-	-	21.41	11.37	31.20	26.71
PEG Ratio	0.67	0.51	0.82	0.54	1.61	0.38

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	1.99	1.48	1.47	1.86	2.52	3.18
EV/EBITDA Ratio	19.67	15.16	16.92	14.74	19.89	20.04
EV/EBIT Ratio	20.71	15.42	17.27	14.98	20.10	20.31
EV/FCF Ratio	-	-	23.64	12.63	34.58	29.96

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.50	0.50	0.31	0.37	0.52	0.65
Debt / EBITDA Ratio	2.10	2.10	1.59	1.27	1.85	1.90
Debt / FCF Ratio	-	-	2.33	1.12	3.33	2.93
Net Debt / Equity Ratio	0.40	0.40	0.20	0.23	0.45	0.52
Net Debt / EBITDA Ratio	1.76	1.76	1.05	0.82	1.68	1.58
Net Debt / FCF Ratio	-4.54	-4.54	1.47	0.70	2.91	2.36
Asset Turnover	1.32	1.32	1.24	1.25	1.14	1.12
Inventory Turnover	2.35	2.35	2.38	2.34	2.21	2.04
Quick Ratio	1.03	1.03	1.25	1.15	1.12	1.30
Current Ratio	2.24	2.24	2.51	2.30	2.38	2.67
Return on Equity (ROE)	13.66%	13.66%	12.33%	19.38%	15.72%	40.14%
Return on Assets (ROA)	7.90%	7.90%	6.58%	9.67%	8.93%	10.96%
Return on Invested Capital (ROIC)	10.29%	11.70%	11.21%	16.02%	13.17%	23.92%
Return on Capital Employed (ROCE)	16.20%	16.20%	13.90%	20.30%	18.20%	20.70%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	3.18%	4.18%	4.24%	4.75%	2.94%	5.25%
FCF Yield	-2.08%	-2.74%	4.57%	8.76%	3.15%	3.66%
Dividend Yield	0.57%	0.75%	0.68%	0.52%	0.33%	-
Payout Ratio	12.81%	12.81%	14.03%	7.39%	-	-
Buyback Yield / Dilution	-	-	-	-0.02%	-0.16%	-1.34%
Total Shareholder Return	0.57%	0.75%	0.68%	0.50%	0.17%	-1.34%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 21, 2026

Data Sources Report a data error